|
names to irbesartan preparations, avapro 150 mg CoAprovel, Karvezide, Avalide and Avapro HCT.[edit] References^ Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, avapro 150 mg RC, Rohde R, Raz I; Collaborative Study Group. (2001). "Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with.
S, editor. Australian Medicines Handbook; 2006. ISBN 0-9757919-2-3 IrbesartanFrom Wikipedia, the free encyclopedia(Redirected from Avapro)Jump to: navigation, searchIrbesartanSystematic (IUPAC) name2-butyl-3-[p-(o-1H-tetrazol-5-ylphenyl)benzyl]-1,3-diazaspiro[4.4]non-1-en-4-oneIdentifiersCAS number 138402-11-6ATC code C09CA04PubChem 3749DrugBank APRD00413Chemical dataFormula C25H28N6OMol. mass 428.53SMILES avapro 150 mg & PubChemPharmacokinetic dataBioavailability 60–80%Metabolism Hepatic (CYP2C9)Half life 11–15 hoursExcretion Renal 20%, faecal 65%Therapeutic considerationsLicence avapro 150 mg EU, USPregnancy cat. D (Au)Legal avapro 150 mg S4 (Au), POM avapro 150 mg ?-only (U.S.)Routes OralIrbesartan (INN) (pronounced /?rb??s?rt?n/) is avapro 150 mg angiotensin II receptor antagonists, irbesartan is indicated for the treatment of hypertension. Irbesartan was developed by Sanofi Research (now part of sanofi-aventis). It is jointly marketed by sanofi-aventis and Bristol-Myers Squibb avapro 150 mg the trade names Aprovel, Karvea, and.
dataFormula C25H28N6OMol. mass 428.53SMILES eMolecules & PubChemPharmacokinetic dataBioavailability 60–80%Metabolism Hepatic (CYP2C9)Half.
| 
Comments
I have found it!
__________________
http://shop-med.org pharma shop
__________________
http://shop-med.org pharma shop
__________________
http://shop-med.org pharma shop
To whom is the link to the avapro 150 mg necessary?
__________________
http://shop-med.org pharma shop